This federal contract award, valued at $30,750.00, was issued by the Medical Supply Chain division of the Defense agency to Abbott Laboratories Inc., a large pharmaceutical and medical device manufacturer. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type, and an ultimate completion date of April 3, 2025. The contract does not have a set-aside designation, indicating full and open competition. Abbott Laboratories Inc. has a strong track record of...
This federal contract award, valued at $21,425.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a leading global healthcare company. The contract is a fixed-price delivery order with economic price adjustment, with an ultimate completion date of July 1, 2024. The contract does not have a set-aside designation, indicating full and open competition. Abbott Laboratories Inc. has been a significant federal contractor, particularly in providing advanced cardiovascular...
This federal contract award, valued at $34,732.80, was issued by the Medical Supply Chain division of the Defense agency to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a fixed-price delivery order with economic price adjustment, with a completion date of December 20, 2024. The contract does not have a set-aside designation, indicating full and open competition. Abbott Laboratories Inc. is a major pharmaceutical and medical device manufacturer that has been...
This is a federal contract award to Abbott Laboratories Inc., a large pharmaceutical and medical device manufacturer, to provide a range of cardiovascular medical devices and related services to the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The $11,750.00 fixed-price delivery order contract has a performance period ending on March 3, 2025. The contract was awarded by the Defense Logistics Agency (DLA) without any set-aside designation, indicating...
This is a federal contract award to Abbott Laboratories Inc., a large pharmaceutical and medical device manufacturer, for the delivery of cardiovascular medical devices and related services. The contract, valued at $25,364.85, was awarded by the Defense Logistics Agency (DLA) and is a fixed-price delivery order contract with economic price adjustment. The contract has a completion date of February 5, 2025 and does not include a set-aside designation, indicating full and open competition....
This federal contract award, valued at $26,275.85, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a major pharmaceutical and medical device manufacturer. The contract is a fixed-price delivery order with an economic price adjustment clause, tasking Abbott Vascular Inc., a division of Abbott Laboratories, to provide a range of cardiovascular medical devices and related services to federal healthcare systems, particularly the...
This federal contract award, valued at $9,493.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a global healthcare company specializing in medical devices, diagnostics, and pharmaceuticals. The contract is a fixed-price delivery order with economic price adjustment, with a performance period ending on April 15, 2025. The contract does not have a set-aside designation, indicating it was awarded through full and open...
This federal contract award to Abbott Laboratories Inc., a large pharmaceutical and medical device manufacturer, is a $27,182.00 delivery order contract for the supply of cardiovascular medical devices and related services. The contract was awarded by the Defense Logistics Agency, which provides comprehensive medical supply chain management for the Department of Defense and other federal healthcare systems. The contract is a firm fixed-price with economic price adjustment, and does not have a...
This federal contract award, valued at $14,850.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The award is a Delivery Order contract with a fixed price and economic price adjustment pricing type. The contract has an ultimate completion date of January 31, 2025 and does not include a set-aside designation, indicating full and open competition. Abbott Laboratories Inc. is a major pharmaceutical and medical device...
This federal contract award is a delivery order (SPE2DE24DA010|SPE2D625F22RU) worth $5,695.00 to Abbott Laboratories Inc., a large pharmaceutical and medical device manufacturer, through its Abbott Vascular Inc. division. The contract was awarded by the Defense Logistics Agency, which manages the Medical Supply Chain for the Department of Defense, and has an ultimate completion date of January 16, 2025. The contract is a fixed-price with economic price adjustment and does not have a set-aside...